Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine

Jun 30 2020

• By Derrick Gingery

Doctor, nurse, scientist hand in blue gloves holding flu, measles, coronavirus, covid-19 vaccine disease preparing for child, baby, adult, man and woman vaccination shot, medicine and drug concept. — Pfizer upped its coronavirus vaccine production projection to 1bn doses in 2021. • Source: Shutterstock

Related Content

Moderna: Speed Of COVID-19 Vaccine Now Hinges On Enrolling The Right Patients

Jun 23 2020

Lilly CEO: Monoclonal Antibody Companies Should Share Coronavirus Manufacturing Capacity

Jun 25 2020

Manufacturing Pace Is Key For COVID-19 Vaccine Candidates Hoping To Jump To ‘Warp Speed’

Jun 17 2020

BIO 2020 Notebook: FDA's Hahn On COVID-19 Lessons To Be Learned; NIH's Fauci On Health Care Disparities; Pfizer's Young On Forgoing Gov't Vaccine Funds

Jun 11 2020

Pfizer’s Bourla On COVID-19 Vaccine: "There Is No ROI That Will Drive Our Decision"

Jun 22 2020

Gilead Sets Remdesivir Price, Commits Nearly All Near-Term Supplies To US

Jun 30 2020

Operation Warp Speed Shortlist Not Decided Yet, Says Novavax

Jun 15 2020

COVID-19: The Race To Develop A Vaccine

Jun 09 2020

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Eli Lilly and Company

AstraZeneca PLC

Gilead Sciences, Inc.

Additional Topics

Coronavirus COVID-19 Vaccines Pricing Strategies Commercial BioPharmaceutical

More from COVID-19

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window